Biotechnology Systems Biology Law In Ukraine.
1. Introduction
Biotechnology Systems Biology Law in Ukraine concerns the legal regulation of scientific research and commercial activities involving the integrated study of biological systems, including genes, proteins, cells, tissues, microorganisms, metabolic pathways and entire living organisms.
Systems biology is an interdisciplinary scientific approach that combines:
Molecular biology and genetics.
Genomics and proteomics.
Bioinformatics and computational biology.
Synthetic biology and genetic engineering.
Systems medicine and personalised healthcare.
Artificial intelligence in biological research.
Biological data collection and analysis.
Agricultural and environmental biotechnology.
Unlike conventional biotechnology, which may examine a particular gene, protein or biological process independently, systems biology investigates how different biological components interact as an integrated system.
Ukraine does not have a separate statute entitled the Systems Biology Act. Instead, systems biology is regulated through a combination of biotechnology, genetic-engineering, biosafety, pharmaceutical, medical-research, environmental, intellectual-property and personal-data laws.
An important recent development is the introduction of Ukraine's Law No. 3339-IX of 23 August 2023, which entered into force on 16 September 2026. It establishes a substantially updated framework for genetic-engineering activities and the regulation of genetically modified organisms (GMOs).
Офіційний портал Верховної Ради України+1
2. Constitutional and Legal Foundations
The Ukrainian Constitution provides the fundamental principles governing biotechnology research.
Important constitutional provisions include:
Article 3 – Human dignity and safety
Human life, health and dignity are recognised as important constitutional values. Biotechnology research must respect human dignity and individual rights.
Article 28 – Human dignity and integrity
This provision is relevant to medical experimentation, genetic interventions and research involving human biological materials.
Article 32 – Privacy
Genetic information, medical records and identifiable biological data can raise constitutional privacy concerns.
Article 50 – Environmental rights
Individuals have a constitutional right to an environment that is safe for life and health.
These constitutional principles influence the interpretation and enforcement of biotechnology legislation.
3. Principal Legislation Governing Systems Biology
Ukraine regulates systems biology through several interconnected legal instruments.
| Legislation | Legal significance |
|---|---|
| Law No. 3339-IX of 2023 | Genetic engineering and GMO regulation |
| Law No. 123/96-VR of 1996 | Medicinal products and pharmaceutical biotechnology |
| Law No. 2297-VI of 2010 | Protection of personal data |
| Law No. 1264-XII of 1991 | Environmental protection |
| Law No. 2801-XII of 1992 | Healthcare rights and medical experimentation |
| Law No. 3687-XII of 1993 | Protection of inventions and patents |
| Law No. 2573-IX of 2022 | Public health regulation |
The laws operate together rather than establishing a single regulatory system specifically for systems biology.
від 23.08.2023 № 3339-IX+3
4. Genetic Engineering and Systems Biology Regulation
Law No. 3339-IX of 23 August 2023
The Law of Ukraine on State Regulation of Genetic Engineering Activities and State Control over the Placement on the Market of Genetically Modified Organisms and Products is central to the regulation of genetic-engineering activities.
It became fully effective on 16 September 2026, replacing the previous 2007 GMO biosafety law.
Офіційний портал Верховної Ради України+1
Its regulatory framework covers several important activities.
A. Contained genetic-engineering activities
Research institutions and biotechnology laboratories conducting genetic-engineering experiments must comply with applicable biosafety requirements.
Examples include:
Genetic modification of microorganisms.
Recombinant DNA experiments.
Genetically engineered cell cultures.
Laboratory production of modified biological organisms.
Research involving genetically modified biological materials.
The level of risk and applicable containment requirements are important considerations.
B. Open-system experiments
Research involving the deliberate release or testing of GMOs outside contained laboratory environments requires the applicable governmental authorisation.
Examples include genetically modified plants, environmental field experiments and agricultural biotechnology trials.
C. State registration
The legislation establishes a state-registration framework for GMOs and regulates their placement on the market.
D. Product labelling and traceability
Businesses involved in GMO products must comply with applicable identification, labelling and traceability requirements.
E. Government supervision
Regulatory authorities may investigate violations, require corrective measures and apply statutory enforcement mechanisms.
These requirements are relevant to systems biology when research involves organisms or products falling within the statutory definition of GMOs.
від 23.08.2023 № 3339-IX+1
5. Regulation of Genomics, Proteomics and Bioinformatics
Systems biology depends heavily on large-scale biological information.
Genomics examines the complete genetic material of an organism, while proteomics studies the proteins expressed by biological systems.
Bioinformatics combines biological information with computational methods to understand biological interactions.
Ukraine's legal framework raises several issues.
1. Genetic information protection
Genetic information can reveal highly personal information about individuals and their biological relatives.
Research institutions must consider the Ukrainian personal-data protection framework, including Law No. 2297-VI of 2010.
2. Data collection and consent
Where research involves identifiable human biological information, researchers must establish an appropriate legal basis for processing and comply with applicable consent and confidentiality requirements.
3. International data transfers
Where genomic datasets are transferred to foreign universities, pharmaceutical companies or international research institutions, applicable personal-data transfer requirements must be considered.
4. Cybersecurity
Biological databases and research platforms require appropriate technical and organisational safeguards.
5. Artificial intelligence
AI-based systems biology may involve predictive genetic models, disease simulations and computational drug discovery. Their use can raise questions concerning scientific reliability, privacy, discrimination and accountability.
6. Systems Biology in Medical and Pharmaceutical Research
Systems biology has significant applications in Ukrainian healthcare.
Examples include:
Precision medicine.
Genomic disease diagnosis.
Cancer biology.
Drug discovery.
Pharmacogenomics.
Stem-cell research.
Molecular diagnostics.
Biological drug development.
Personalised treatment models.
Ukraine's medicinal-products legislation and clinical-trial regulations provide the relevant regulatory framework.
The State Expert Center of the Ministry of Health plays an important role in the assessment of clinical-trial applications and related documentation.
Ministry of Health Order No. 690 of 23 September 2009 establishes procedures concerning clinical trials of medicinal products and ethics committees.
The Ukrainian regulatory framework also incorporates Good Clinical Practice requirements. The State Expert Center published an updated ICH E6(R3) Good Clinical Practice guideline in 2025, with the relevant guidance available in its 2026 regulatory materials.
Державний експертний центр МОЗ України+2
Important legal requirements
Appropriate scientific justification for research.
Ethics committee review where required.
Informed consent from research participants.
Protection of medical confidentiality.
Appropriate monitoring of clinical trials.
Reporting and management of adverse events.
Compliance with applicable medicinal-product authorisation requirements.
A systems biology experiment involving human participants cannot avoid medical-research safeguards merely because it uses computational or molecular techniques.
7. Environmental and Agricultural Systems Biology
Systems biology is also relevant to agricultural and environmental protection.
Applications include:
Genetically modified crops.
Microbial soil engineering.
Plant genomics.
Agricultural disease resistance.
Biological fertilisers.
Environmental microbiology.
Ecosystem modelling.
Climate-resilient agricultural biotechnology.
The new GMO legislation is particularly important where agricultural research involves genetically modified organisms.
Ukraine must also consider its international environmental obligations, including the Cartagena Protocol on Biosafety, which addresses the safe handling, transport and use of living modified organisms resulting from modern biotechnology.
The new statutory framework also establishes controls over GMO imports, exports and transit. The World Trade Organization has published Ukraine's relevant restrictions under the new legislation, including restrictions relating to unregistered GMOs.
WTO Quantitative Restrictions+2
8. Intellectual Property Rights in Systems Biology
Intellectual-property protection is important for biotechnology universities, pharmaceutical companies and private research organisations.
Ukraine's patent legislation, particularly Law No. 3687-XII on Protection of Rights to Inventions and Utility Models, provides the principal framework.
Potentially patentable inventions may include:
New biotechnology processes.
Industrial biological production methods.
Novel diagnostic technologies.
Engineered biological applications.
Technical methods of drug production.
New laboratory technologies.
However, scientific discoveries, biological facts and naturally occurring phenomena are not automatically patentable merely because they have been identified through advanced research.
Patent applicants must satisfy applicable requirements concerning novelty, inventive step and industrial applicability.
Important legal questions
Who owns inventions developed through university research?
Can pharmaceutical companies claim rights over jointly developed technologies?
How should ownership of AI-assisted biological inventions be determined?
Can confidential genomic databases be commercially licensed?
How should research agreements allocate ownership of biological materials and research results?
These questions require consideration of patent law, contractual obligations, employment relationships and research-funding agreements.
9. Government Regulatory Authorities
Several public institutions have responsibilities relevant to systems biology.
| Authority | Principal responsibility |
|---|---|
| Ministry of Health | Health and pharmaceutical policy |
| State Expert Center | Medicinal-product expertise and clinical trials |
| Ministry responsible for environmental policy | Environmental and biosafety policy |
| Relevant GMO market-control authorities | GMO market supervision |
| Ukrainian patent authorities | Intellectual-property administration |
| Personal-data supervisory institutions | Personal-data protection within their statutory powers |
The allocation of responsibilities depends on the particular activity and the legislation applicable to it.
10. Important Case Laws Relating to Systems Biology and Biotechnology
There is an important distinction between judgments directly concerning systems biology and judgments establishing legal principles applicable to systems biology.
There is no clearly established Ukrainian appellate precedent specifically deciding the legal regulation of systems biology as a standalone scientific discipline. The following cases are relevant by analogy.
Case 1. Mayboroda v. Ukraine (2023)
Important human-rights precedent
Court: European Court of Human Rights (ECtHR).
Application No.: 14709/07.
Judgment date: 13 April 2023.
Legal provision: Article 8, European Convention on Human Rights.
Facts:
The applicant underwent emergency surgery at a Ukrainian hospital. During the operation, doctors removed her previously healthy kidney without obtaining her informed consent to that particular intervention.
The applicant subsequently challenged the medical treatment and the absence of adequate safeguards.
Judgment:
The European Court found a violation of Article 8 because Ukraine had failed to provide an adequate regulatory framework protecting the applicant's right to informed consent.
Relevance to systems biology:
This judgment is relevant to:
Genomic research involving patients.
Biological sample collection.
Molecular diagnostic procedures.
Experimental biotechnology treatments.
Research involving human tissues.
Personalised medical interventions.
Legal principle: Medical research and interventions must respect patient autonomy, informed consent and private life.
Source:
HUDOC+1
Case 2. Confédération paysanne and Others v. Premier ministre and Ministre de l'Agriculture (2018)
Court: Court of Justice of the European Union (CJEU).
Case No.: C-528/16.
Judgment date: 25 July 2018.
Facts:
The dispute concerned genetically modified organisms produced through mutagenesis techniques.
The central question was whether organisms produced through newer genetic-modification techniques were covered by European GMO legislation.
Judgment:
The CJEU held that organisms obtained through mutagenesis techniques generally fell within the GMO regulatory framework, subject to the applicable exemptions for established techniques.
Relevance to Ukraine:
The judgment is useful when considering:
Gene-editing technologies.
Genetic-engineering classifications.
New biotechnology techniques.
GMO identification.
Agricultural systems biology.
Environmental risk assessment.
It is a comparative European authority, not a binding Ukrainian national judgment.
Law Gratis+1
Case 3. Institute of Cell Therapy Investigation, Kyiv (2013)
Court: Pechersky District Court of Kyiv.
Case No.: 757/22528/13-к.
Date: 16 October 2013.
Facts:
The judicial proceeding concerned an investigation into alleged unlawful activities involving cellular therapies and the use of biological materials, including umbilical-cord blood and placental materials.
Issues included the legality of biological-material procurement, consent and the regulatory status of cellular-therapy activities.
Legal significance:
The proceedings illustrate the importance of:
Lawful collection of biological materials.
Donor consent.
Institutional authorisation.
Proper storage and handling of biological samples.
Compliance with transplantation legislation.
Important qualification: This was a procedural ruling connected with a criminal investigation. It should not be treated as a final conviction or proof that all allegations were established.
Law Gratis
11. Civil and Criminal Liability in Systems Biology
Biotechnology research may create different categories of legal liability.
| Type of liability | Examples |
|---|---|
| Civil liability | Injury caused by defective biological products |
| Criminal liability | Unlawful medical experimentation or other criminal conduct |
| Administrative liability | Violation of GMO regulatory requirements |
| Environmental liability | Damage caused by unlawful biological releases |
| Contractual liability | Breach of biotechnology research agreements |
| Data-protection liability | Unlawful processing or disclosure of genetic information |
| Intellectual-property liability | Patent infringement or unlawful commercial exploitation |
Under the new GMO legislation, violations can trigger regulatory intervention and statutory responsibility.
For example, a biotechnology company that releases an unregistered genetically modified organism into the environment may face enforcement action under the applicable legislation.
Similarly, a research institution that improperly discloses identifiable genomic information may face legal consequences under personal-data and other applicable laws.
12. Major Legal Challenges
Ukraine faces several important challenges in regulating systems biology.
A. Regulatory uncertainty
Systems biology combines several scientific disciplines. Determining which legal regime applies to a particular research activity can be complicated.
B. Genetic-data privacy
Genomic information may reveal information about both research participants and their biological relatives.
C. AI accountability
Researchers may rely on computational models to predict biological outcomes. Incorrect predictions can create scientific, medical and legal risks.
D. Cross-border research
International research collaborations require compliance with applicable rules concerning biological materials, research data, intellectual property and GMO transfers.
E. Environmental protection
Genetically modified organisms may create environmental risks that require appropriate scientific assessment and monitoring.
F. Research commercialisation
Universities, investors and pharmaceutical companies may disagree over ownership of inventions, datasets, biological materials and research results.
G. Wartime research infrastructure
Damage to laboratories, biological sample repositories and scientific infrastructure creates additional challenges involving research continuity, sample security and institutional responsibility.
13. Relationship with European Union Law
Ukraine's biotechnology legislation is increasingly influenced by European regulatory standards.
Important European legal instruments and principles include:
Directive 2001/18/EC on the deliberate release of genetically modified organisms.
Regulation (EC) No. 1829/2003 on genetically modified food and feed.
Regulation (EC) No. 1830/2003 on GMO traceability and labelling.
Regulation (EU) 2016/679 (GDPR), where applicable to personal-data processing within its territorial scope.
Regulation (EU) No. 536/2014 on clinical trials of medicinal products for human use, relevant to the EU regulatory framework.
Ukraine's Law No. 3339-IX is an important part of its legislative alignment with European GMO regulatory requirements. However, European regulations do not automatically become Ukrainian domestic legislation merely because Ukraine is aligning its legal system with the EU.
14. Conclusion
Biotechnology Systems Biology Law in Ukraine is an emerging interdisciplinary legal field rather than a separate statutory subject.
Its legal foundation consists of genetic-engineering regulation, environmental protection, pharmaceutical legislation, clinical-trial rules, personal-data protection and intellectual-property rights.
The introduction of Law No. 3339-IX in September 2026 represents an important development in Ukraine's GMO regulatory framework.
The judgments in Mayboroda v. Ukraine and Confédération paysanne provide useful principles concerning informed consent, human rights, genetic modification and biotechnology regulation.
Ultimately, the Ukrainian legal framework must balance five important objectives:
Scientific innovation and biotechnology development.
Protection of human dignity and patient autonomy.
Genetic and biological safety.
Environmental and agricultural protection.
Responsible commercialisation of scientific discoveries.
The central legal principle is that scientific advancement in systems biology must operate within a framework of human-rights protection, scientific accountability, biosafety and environmental responsibility.
15. Important Legal References for Further Research
| Legal source | Subject |
|---|---|
| Constitution of Ukraine | Fundamental rights |
| Law No. 3339-IX (2023) | Genetic engineering and GMO regulation |
| Law No. 2297-VI (2010) | Personal-data protection |
| Law No. 123/96-VR (1996) | Medicinal products |
| Law No. 2801-XII (1992) | Healthcare and medical experimentation |
| Law No. 3687-XII (1993) | Patent protection |
| Law No. 1264-XII (1991) | Environmental protection |
| Cartagena Protocol on Biosafety | International biosafety obligations |
Official research resources:
Ukrainian Law No. 3339-IX – Official legislation
State Expert Center – Clinical-trial legislation
Unified State Register of Court Decisions of Ukraine
Ukrainian Parliament – New GMO legislation effective September 2026
Research note: This is an academic legal explanation, not individual legal advice. For litigation or regulatory compliance, the current Ukrainian-language statutory text and implementing regulations should be consulted.

comments